Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study-Reference-Cited by-同舟云学术

Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study

Published:2016-05-27 Issue:7 Volume:31 Page:1152-1160
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrol. Dial. Transplant.

Author:

Tanaka Shigeru,Ninomiya Toshiharu,Taniguchi Masatomo,Fujisaki Kiichiro,Tokumoto Masanori,Hirakata Hideki,Ooboshi Hiroaki,Kitazono Takanari,Tsuruya Kazuhiko

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/31/7/1152/17173043/gfw205.pdf

Reference41 articles.

1. Vitamin D levels and patient outcome in chronic kidney disease

2. Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease

3. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients

4. Vitamin D in inflammatory diseases;Wobke;Front Physiol,2014

5. Inflammation and vitamin D: the infection connection

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10‐Year Outcomes of the Q‐Cohort Study;Journal of the American Heart Association;2024-08-06

2. Exploring factors associated with bleeding events after open heart surgery in patients on dialysis − effects of the presence or absence of warfarin therapy;Journal of Pharmaceutical Health Care and Sciences;2024-07-12

3. Relationships of Weight Change from 20 Years of Age with the Risks of All-Cause and Cardiovascular Mortality in Patients with Chronic Kidney Disease;Journal of Atherosclerosis and Thrombosis;2024-07-01

4. Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study;Clinical and Experimental Nephrology;2022-09-13

5. Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients receiving dialysis;Clinical and Experimental Nephrology;2022-03-30